Investor Jeremy Grantham has criticized SpaceX’s recent Nasdaq 100 debut, labeling the aerospace company’s ambitious multiplanetary mission statement as a historic example of market irrationality and future folly.

Key Points

• SpaceX recently joined the Nasdaq 100, integrating the aerospace firm into global investment portfolios and major market indices.
• Jeremy Grantham, co-founder of GMO, publicly dismissed the company's prospectus goals as laughable and unsustainable for long-term investors.
• Shares are currently trading near $150, reflecting a 7% decline over the past month and hovering slightly above the initial $135 launch price.
• Major financial institutions remain divided on valuation, with price targets ranging from $205 by Goldman Sachs to $300 by Morgan Stanley.
• Analysts at J.P. Morgan noted that while reaching $1 trillion in revenue by 2031 is possible, it requires flawless execution and faces significant leadership-transition risks.
• Elon Musk maintains 82% voting power, a concentration of control that analysts identify as both a primary driver of success and a potential governance concern.

Why it Matters

The inclusion of SpaceX in the Nasdaq 100 exposes millions of retail and institutional investors to the high-risk, high-reward nature of the private space industry. This debate highlights the tension between visionary corporate goals and traditional financial valuation, particularly regarding the risks associated with founder-led companies.